首页 > 市场调查报告书 > 製药

再生医学细胞疗法

北美生物生产市场预测至 2030 年 - 区域分析 - 按产品、应用、设备和最终用户

市场调查报告书

商品编码

1510610

北美生物生产市场预测至 2030 年 - 区域分析 - 按产品、应用、设备和最终用户

North America Bioproduction Market Forecast to 2030 - Regional Analysis - by Product, Application, Equipment, and End User

出版日期: 2024年05月07日 | 出版商:

The Insight Partners | 英文 95 Pages | 订单完成后即时交付

价格

简介目录图表

2022年北美生物生产市场价值为109.4748亿美元，预计2030年将达到313.7365亿美元；预计2022年至2030年复合年增长率为14.1%。

再生药物的不断采用推动了北美生物生产市场

再生疗法有助于细胞、组织和器官的再生，以恢復其功能。每年都会向美国食品药物管理局（FDA）提交一些人体临床试验的再生医学申请。根据再生医学联盟的数据，2019年第三季度，全球正在进行1,052项利用再生医学的临床试验； 2019 年正在进行 218 项细胞疗法试验（41 项 I 期试验、147 项 II 期试验、30 项 III 期试验）。细胞疗法是再生医学领域成长最快的领域之一。诺华的 Kymriah 是第一个用于治疗 B 细胞急性白血病的细胞治疗解决方案。此外，再生医学提供者RepliCel拥有多种再生医学产品正在研发中，其中RCH-01、RCS-01和RCT-01这三个产品正处于开发阶段。此外，Sernova 致力于再生医学技术的开发，并拥有针对糖尿病、A 型血友病和甲状腺功能亢进等疾病的庞大产品线。因此，再生药物的日益普及正在推动生物生产市场的发展。

北美生物生产市场概况

北美生物生产市场细分为美国、加拿大和墨西哥。在墨西哥，由于干细胞治疗的医疗旅游业不断增长，对细胞治疗的需求非常引人注目。由于糖尿病和不孕症发病率的增加以及生物相似药产品开发的不断增加，北美的生物生产市场在 2022 年占据了最大的市场份额。

遗传和细胞疾病发病率的不断上升导致对细胞疗法的需求不断增加。 2020 年 PhRMA 关于细胞和基因治疗管道的报告显示，美国有 400 种细胞和基因疗法正在开发中，以针对从癌症到遗传性疾病到神经系统疾病等多种疾病和病症。截至2020年2月，有九种细胞或基因治疗产品在美国获得批准，用于治疗癌症、眼部疾病和罕见遗传疾病。此外，越来越多的新创公司正在该国创新细胞疗法。

北美生物生产市场收入及 2030 年预测（百万美元）

北美生物生产市场细分

北美生物生产市场分为产品、应用、设备、最终用户和国家。

根据产品，北美生物生产市场分为生物製剂和生物相似药、疫苗、细胞和基因疗法、核酸疗法等。 2022 年，生物製剂和生物相似药领域占据北美最大的生物生产市场。

在应用方面，北美生物生产市场分为类风湿性关节炎、血液疾病、癌症、糖尿病、心血管疾病等。到 2022 年，癌症领域将占据北美最大的生物生产市场。

依设备划分，北美生物生产市场分为上游设备、下游设备、生物反应器、耗材及配件。 2022 年，消耗品和配件领域占据北美最大的生物生产市场。

就最终用户而言，北美生物生产市场分为生物製药公司、合约製造组织等。 2022 年，生物製药公司细分市场占据北美最大的生物生产市场。

按国家/地区划分，北美生物生产市场分为美国、加拿大和墨西哥。 2022年，美国在北美生物生产市场份额中占据主导地位。

Bio-Rad Laboratories Inc、丹纳赫公司、F. Hoffmann-La Roche Ltd、Lonza Group AG、Merck KGaA、Sartorius AG 和 Thermo Fisher Scientific Inc. 是北美生物生产市场上的一些领先公司。

Regenerative therapies help in the regeneration of cells, tissues, and organs to restore their functions. A number of regenerative medicine applications for human clinical trials are submitted to the Food and Drug Administration (FDA) each year. As per the Alliance for Regenerative Medicine, in 2019 (Q3), 1,052 clinical trials utilizing regenerative medicine were underway globally; 218 cellular therapy trials were underway (41 Phase I, 147 Phase II, 30 Phase III) in 2019. Rapid advancements are being made in regenerative medicines to provide effective solutions for chronic conditions. Cell therapy is one of the fastest-growing segments of the regenerative medicine domain. Novartis' Kymriah was the first cell therapy solution offered to treat B-cell acute leukemia. Moreover, RepliCel, a regenerative medicine provider, has a wide range of regenerative medicine products in the pipeline, with three products-RCH-01, RCS-01, and RCT-01-in the development phase. Further, Sernova is engaged in the development of regenerative medicine technologies and has a huge pipeline of products for conditions such as diabetes, hemophilia A, and hyperthyroidism. Thus, the rising adoption of regenerative medicines is driving the bioproduction market.

North America Bioproduction Market Overview

The North America bioproduction market is subsegmented into the US, Canada, and Mexico. In Mexico, the demand for cell therapy is quite noteworthy owing to growing medical tourism for stem cell therapy. The bioproduction market in North America accounted for the largest market share in 2022 due to increasing incidence of diabetes and infertility, as well as rising product developments in biosimilars.

Growing incidences of genetic and cellular disorders are leading to increasing demand for cell therapies. A 2020 PhRMA report on the cell and gene therapy pipeline revealed that there are 400 cell and gene therapies in development to target a variety of diseases and conditions from cancer to genetic disorders to neurologic conditions in the US. As of February 2020, nine cell or gene therapy products were approved in the US to treat cancer, eye diseases and rare hereditary diseases. Also, an increasing number of start-ups are innovating cell therapies in the country.

North America Bioproduction Market Revenue and Forecast to 2030 (US$ Million)

North America Bioproduction Market Segmentation

The North America bioproduction market is categorized into product, application, equipment, end user, and country.

Based on product, the North America bioproduction market is segmented into biologics and biosimilars, vaccines, cell and gene therapies, nucleic acid therapeutics, and others. The biologics and biosimilars segment held the largest North America bioproduction market share in 2022.

In terms of application, the North America bioproduction market is segmented into rheumatoid arthritis, hematological disorders, cancer, diabetes, cardiovascular diseases, and others. The cancer segment held the largest North America bioproduction market share in 2022.

By equipment, the North America bioproduction market is divided into upstream equipment, downstream equipment, bioreactors, and consumables and accessories. The consumables and accessories segment held the largest North America bioproduction market share in 2022.

In terms of end user, the North America bioproduction market is categorized into biopharmaceutical companies, contract manufacturing organizations, and others. The biopharmaceutical companies segment held the largest North America bioproduction market share in 2022.

By country, the North America bioproduction market is segmented into the US, Canada, and Mexico. The US dominated the North America bioproduction market share in 2022.

Bio-Rad Laboratories Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Lonza Group AG, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc. are some of the leading companies operating in the North America bioproduction market.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Bioproduction Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rising Adoption of Regenerative Medicines
- 4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
- 4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
- 4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
- 4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis

5. Bioproduction Market - North America Market Analysis

5.1 North America Bioproduction Market Revenue (US$ Mn), 2020 - 2030

6. North America Bioproduction Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
- 6.3.1 Overview
- 6.3.2 Biologics and Biosimilars: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
- 6.4.1 Overview
- 6.4.2 Vaccines: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
- 6.5.1 Overview
- 6.5.2 Cell and Gene Therapies: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
- 6.6.1 Overview
- 6.6.2 Nucleic Acid Therapeutics: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
- 6.7.1 Overview
- 6.7.2 Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Bioproduction Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
- 7.3.1 Overview
- 7.3.2 Cancer: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
- 7.4.1 Overview
- 7.4.2 Cardiovascular Diseases: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
- 7.5.1 Overview
- 7.5.2 Rheumatoid Arthritis: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
- 7.6.1 Overview
- 7.6.2 Hematological Disorders: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
- 7.7.1 Overview
- 7.7.2 Diabetes: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

8.1 Overview
8.2 North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
- 8.3.1 Overview
- 8.3.2 Consumables and Accessories: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
- 8.4.1 Overview
- 8.4.2 Downstream Equipment: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
- 8.5.1 Overview
- 8.5.2 Bioreactors: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.5.2.1 North America: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
- 8.6.1 Overview
- 8.6.2 Upstream Equipment: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Bioproduction Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
- 9.3.1 Overview
- 9.3.2 Biopharmaceutical Companies: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
- 9.4.1 Overview
- 9.4.2 Contract Manufacturing Organizations: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

10.1 North America: Bioproduction Market
- 10.1.1 US: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.1 Overview
  - 10.1.1.2 US: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
  - 10.1.1.3 US: Bioproduction Market, by Product, 2020-2030 (US$ Million)
  - 10.1.1.4 US: Bioproduction Market, by Application, 2020-2030 (US$ Million)
  - 10.1.1.5 US: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.5.1 US: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
  - 10.1.1.6 US: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.2 Canada: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Canada: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.2.4 Canada: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.2.5 Canada: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.5.1 Canada: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.2.6 Canada: Bioproduction Market, by End User, 2020-2030 (US$ Million)
  - 10.1.1.3 Mexico: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 Mexico: Bioproduction Market, by Product, 2020-2030 (US$ Million)
    - 10.1.1.3.4 Mexico: Bioproduction Market, by Application, 2020-2030 (US$ Million)
    - 10.1.1.3.5 Mexico: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.5.1 Mexico: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
    - 10.1.1.3.6 Mexico: Bioproduction Market, by End User, 2020-2030 (US$ Million)

11. Bioproduction Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Lonza Group AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Danaher Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sartorius AG
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Merck KGaA
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Bioproduction Market Segmentation
Table 2. North America Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. US Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. US Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. US Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. US Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 7. US Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 19. Recent Organic Growth Strategies in the Bioproduction Market
Table 20. Glossary of Terms, Bioproduction Market

List Of Figures

Figure 1. North America Bioproduction Market Segmentation, By Country
Figure 2. North America Bioproduction Market: Key Industry Dynamics
Figure 3. North America Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. North America Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. North America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. North America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. North America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. North America: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. US: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Canada: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Mexico: North America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Growth Strategies in the Bioproduction Market